Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs Eli Lilly will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer's drug and highly popular weight loss and diabetes treatments, among other medicines, in Ireland. The ... 09/11/2024 - 12:59 pm | View Link
Eli Lilly: Zepbound Price Cuts Have Multiple Positives, Limited Downside Eli Lilly's weight loss treatment Zepbound might be a blockbuster in the making, but it wasn't without its challenges. See why I continue to rate LLY stock a buy. 09/4/2024 - 12:09 am | View Link
Lilly cuts price on weight-loss drug Zepbound, selling it in single-dose vials Related Study shows shift in GLP-1 drug use for obesity, not diabetes Weight loss drug Zepbound outperforms ... Advertisement Lilly said buying the vials direct from the company cuts cost by "removing ... 08/27/2024 - 1:07 am | View Link
Eli Lilly's weight-loss drug cuts diabetes risk by 94% in three-year trial London: Eli Lilly's weight-loss drug cut the risk of developing type 2 diabetes by 94 per cent in pre-diabetic adults who were overweight or obese after three years of weekly injections ... 08/20/2024 - 1:10 pm | View Link
Eli Lilly’s weight loss drug dramatically cuts risk of diabetes, company says Eli Lilly’s antidiabetic medication Zepbound cuts the risk of developing Type 2 diabetes by 94 percent in prediabetic adults and those who are overweight or obese, the company said Tuesday. 08/20/2024 - 12:09 pm | View Link